Table 1 Patient characteristics with selected blood samples.
From: Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
Zinc acetate 50 mg × 3 (n = 10) | Zinc acetate 150 mg × 1 (n = 9) | Zinc gluconate 50 mg × 3 (n = 9) | Zinc gluconate 150 mg × 1 (n = 9) | ||
|---|---|---|---|---|---|
Sex | |||||
Male | 4 | 4 | 4 | 1 | |
Female | 6 | 5 | 5 | 8 | NS |
Age (years) | 62.3 (8.2) | 59.6 (18.6) | 63.6 (9.4) | 59.0 (5.8) | NS |
Body mass index (kg/m2) | 23.2 (3.3) | 23.4 (2.5) | 24.3 (2.3) | 23.6 (3.1) | NS |
Serum zinc (µmol/L) | 11.3 (1.7) | 12.3 (2.5) | 11.0 (1.0) | 11.4 (1.6) | NS |
ALT1 (U/L) | 25.2 (13.2) | 27.8 (10.1) | 20.7 (7.5) | 24.7 (8.8) | NS |
Bilirubin (µmol/L) | 10.4 (2.8) | 12.2 (6.0) | 14.4 (4.7) | 11.3 (5.7) | NS |
Albumin (g/L) | 41.2 (1.2) | 41.2 (1.2) | 40.7 (2.2) | 42.2 (2.6) | NS |
Creatinine (µmol/L) | 69.6 (13.1) | 61.9 (11.6) | 65.9 (10.9) | 61.1 (7.0) | NS |
